NASDAQ:TORC

resTORbio SEC Filings & 10K Form

Notice: This company has been marked as potentially delisted and may not be actively trading.
$12.20
-0.04 (-0.33 %)
(As of 04/19/2021 12:00 AM ET)
Add
Compare
Today's Range
$12.15
Now: $12.20
$12.60
50-Day Range
$2.28
MA: $12.16
$14.77
52-Week Range
$0.86
Now: $12.20
$10.50
Volume46,581 shs
Average Volume1.15 million shs
Market Capitalization$444.74 million
P/E RatioN/A
Dividend YieldN/A
Beta2.43

SEC Filings

resTORbio (NASDAQ:TORC) SEC Filings

DateFilerForm TypeView
04/09/2021
3:33 PM
resTORbio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/08/2021
3:37 PM
resTORbio (Issuer)
Schor Chen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2021
5:48 PM
resTORbio (Issuer)
Schor Chen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2021
5:43 PM
resTORbio (Issuer)
Schor Chen (Reporting)
Form 4/A
04/01/2021
5:40 PM
resTORbio (Issuer)
Schor Chen (Reporting)
Form 4/A
03/30/2021
11:15 PM
resTORbio (Filer)
Form EFFECT
03/18/2021
8:55 PM
resTORbio (Issuer)
Schor Chen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2021
7:48 PM
resTORbio (Issuer)
Klickstein Lloyd (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2021
4:25 PM
resTORbio (Filer)
Form DEFA14A
03/18/2021
4:24 PM
resTORbio (Filer)
Form DEF 14A
03/16/2021
6:07 PM
resTORbio (Issuer)
Sinclair Andrew (Reporting)
Form 4/A
03/16/2021
6:06 PM
resTORbio (Issuer)
Sinclair Andrew (Reporting)
Form 3/A
03/16/2021
3:18 PM
Abingworth LLP (Filed by)
resTORbio (Subject)
Form SC 13D/A
03/12/2021
5:44 AM
resTORbio (Filer)
Form S-3
Registration statement under Securities Act of 1933  
03/12/2021
5:26 AM
resTORbio (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/11/2021
8:46 PM
resTORbio (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/11/2021
3:23 PM
resTORbio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/10/2021
6:30 AM
resTORbio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/08/2021
7:30 AM
Abingworth LLP (Filed by)
resTORbio (Subject)
Form SC 13D
03/08/2021
7:15 AM
Abingworth LLP (Filed by)
resTORbio (Subject)
Form SC 13G
03/04/2021
4:18 PM
resTORbio (Issuer)
Sinclair Andrew (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2021
4:17 PM
resTORbio (Issuer)
Sinclair Andrew (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
03/04/2021
4:03 PM
resTORbio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/19/2021
4:22 PM
resTORbio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/18/2021
8:48 PM
resTORbio (Subject)
ORBIMED ADVISORS LLC (Filed by)
Form SC 13D/A
02/18/2021
8:44 PM
resTORbio (Issuer)
Chimovits Erez (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2021
8:41 PM
resTORbio (Issuer)
GORDON CARL L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2021
8:38 PM
resTORbio (Issuer)
OrbiMed Advisors Israel II Ltd (Reporting)
ORBIMED ADVISORS LLC (Reporting)
OrbiMed Capital GP V LLC (Reporting)
OrbiMed Capital GP VI LLC (Reporting)
OrbiMed Israel BioFund GP Limited Partnership (Reporting)
OrbiMed Israel GP II, L.P. (Reporting)
OrbiMed Israel GP Ltd. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2021
6:47 AM
resTORbio (Subject)
Schindel Yair Chaim (Filed by)
Form SC 13D/A
02/17/2021
8:18 PM
ABBOT STEWART (Reporting)
resTORbio (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/17/2021
8:16 PM
resTORbio (Issuer)
Klickstein Lloyd (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/17/2021
8:12 PM
resTORbio (Issuer)
Harvey Brian Nicholas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/17/2021
8:09 PM
resTORbio (Issuer)
Healey Don (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/17/2021
8:09 PM
resTORbio (Issuer)
Krehlik Carrie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/17/2021
8:08 PM
resTORbio (Issuer)
Schor Chen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/17/2021
8:06 PM
resTORbio (Issuer)
Galimi Francesco (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/16/2021
3:01 PM
resTORbio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/12/2021
10:17 AM
resTORbio (Subject)
Avidity Partners Management LP (Filed by)
Form SC 13G
02/11/2021
4:20 PM
resTORbio (Filer)
Form 424B5
02/10/2021
6:38 AM
resTORbio (Filer)
Form S-3MEF
02/01/2021
7:34 AM
resTORbio (Subject)
Novartis Bioventures Ltd (Filed by)
Form SC 13G/A
01/28/2021
4:08 PM
resTORbio (Filer)
Form S-8 POS
01/28/2021
4:06 PM
resTORbio (Filer)
Form S-8 POS
12/03/2020
6:03 PM
resTORbio (Issuer)
Sanna Bastiano (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/03/2020
6:00 PM
resTORbio (Issuer)
Sanna Bastiano (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
12/03/2020
12:01 PM
resTORbio (Subject)
Schindel Yair Chaim (Filed by)
Form SC 13D/A
12/01/2020
4:28 PM
resTORbio (Filer)
Form 424B5
12/01/2020
4:21 PM
resTORbio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/01/2020
6:16 AM
resTORbio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/12/2020
3:31 PM
resTORbio (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
11/05/2020
4:18 PM
resTORbio (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/05/2020
3:33 PM
resTORbio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/29/2020
5:43 PM
resTORbio (Issuer)
Healey Don (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/29/2020
5:41 PM
resTORbio (Issuer)
Healey Don (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
10/27/2020
8:42 PM
resTORbio (Issuer)
Schor Chen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/26/2020
3:34 PM
resTORbio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/22/2020
6:15 AM
resTORbio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/08/2020
3:31 PM
resTORbio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/30/2020
4:19 PM
resTORbio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/24/2020
4:12 PM
resTORbio (Subject)
Schindel Yair Chaim (Filed by)
Form SC 13D
09/22/2020
3:05 PM
resTORbio (Subject)
Novartis Bioventures Ltd (Filed by)
Form SC 13G/A
09/21/2020
6:58 AM
resTORbio (Filer)
Form 424B5
09/18/2020
4:12 PM
resTORbio (Subject)
ORBIMED ADVISORS LLC (Filed by)
Form SC 13D/A
09/18/2020
3:30 PM
resTORbio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/18/2020
5:05 AM
resTORbio (Issuer)
DUBIN STEVE (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
09/17/2020
8:56 PM
resTORbio (Issuer)
DUBIN STEVE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/17/2020
8:55 PM
resTORbio (Issuer)
Jakobovits Aya (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/17/2020
8:55 PM
resTORbio (Issuer)
Schindel Yair Chaim (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/17/2020
8:55 PM
resTORbio (Issuer)
Klickstein Lloyd (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/17/2020
8:51 PM
resTORbio (Issuer)
Schor Chen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/17/2020
8:50 PM
resTORbio (Issuer)
Chimovits Erez (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/17/2020
8:50 PM
ABBOT STEWART (Reporting)
resTORbio (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/17/2020
8:50 PM
resTORbio (Issuer)
Chodakewitz Jeffrey (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/17/2020
8:50 PM
resTORbio (Issuer)
Krehlik Carrie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/17/2020
8:48 PM
resTORbio (Issuer)
Galimi Francesco (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/17/2020
8:46 PM
resTORbio (Issuer)
Chimovits Erez (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
09/17/2020
8:46 PM
resTORbio (Issuer)
Galimi Francesco (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
09/17/2020
8:45 PM
resTORbio (Issuer)
OrbiMed Advisors Israel II Ltd (Reporting)
ORBIMED ADVISORS LLC (Reporting)
OrbiMed Capital GP V LLC (Reporting)
OrbiMed Capital GP VI LLC (Reporting)
OrbiMed Israel BioFund GP Limited Partnership (Reporting)
OrbiMed Israel GP II, L.P. (Reporting)
OrbiMed Israel GP Ltd. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/17/2020
8:45 PM
resTORbio (Issuer)
Schindel Yair Chaim (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
09/17/2020
8:44 PM
resTORbio (Issuer)
Jakobovits Aya (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
09/17/2020
8:44 PM
resTORbio (Issuer)
Krehlik Carrie (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
09/17/2020
8:40 PM
resTORbio (Issuer)
GORDON CARL L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/17/2020
8:39 PM
resTORbio (Issuer)
Harvey Brian Nicholas (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
09/17/2020
8:37 PM
ABBOT STEWART (Reporting)
resTORbio (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
09/17/2020
8:37 PM
resTORbio (Issuer)
OrbiMed Advisors Israel II Ltd (Reporting)
OrbiMed Capital GP V LLC (Reporting)
OrbiMed Israel BioFund GP Limited Partnership (Reporting)
OrbiMed Israel GP II, L.P. (Reporting)
OrbiMed Israel GP Ltd. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
09/17/2020
8:34 PM
resTORbio (Issuer)
GORDON CARL L (Reporting)
GORDON CARL L (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
09/17/2020
8:34 PM
resTORbio (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
09/16/2020
8:59 AM
resTORbio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/15/2020
8:09 AM
resTORbio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/21/2020
7:36 AM
resTORbio (Filer)
Form 424B3
08/20/2020
11:15 PM
resTORbio (Filer)
Form EFFECT
08/19/2020
5:16 AM
resTORbio (Filer)
Form S-4/A
08/12/2020
8:30 AM
resTORbio (Filer)
Form S-4/A
07/30/2020
7:01 AM
resTORbio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/29/2020
4:29 PM
resTORbio (Filer)
Form S-4/A
07/28/2020
10:36 AM
resTORbio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/28/2020
10:34 AM
resTORbio (Subject)
Form 425
07/07/2020
3:42 PM
resTORbio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/23/2020
12:26 PM
resTORbio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/23/2020
12:24 PM
resTORbio (Subject)
Form 425
This page was last updated on 4/20/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.